The current landscape of m6A modification in urological cancers
N6-methyladenosine (m6A) methylation is a dynamic and reversible procession of epigenetic modifications. It is increasingly recognized that m6A modification has been involved in the tumorigenesis, development, and progression of urological tumors. Emerging research explored the role of m6A modificat...
Main Authors: | Yaohui Zeng, Cai Lv, Bangbei Wan, Binghao Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-09-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/16023.pdf |
Similar Items
-
The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers
by: Ryan Michael Antar, et al.
Published: (2024-11-01) -
EUROPEAN SECTION OF ONCOLOGICAL UROLOGY (ESOU): NEW DATA IN 2017
by: S. A. Reva
Published: (2018-03-01) -
Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
by: Pengxiao Su, et al.
Published: (2023-03-01) -
Editorial: Urological cancer awareness month – 2022
by: Georgios-Ioannis Verras, et al.
Published: (2024-05-01) -
The role of RNA modification in urological cancers: mechanisms and clinical potential
by: Xuming Zhou, et al.
Published: (2023-12-01)